scholarly journals RELATION BETWEEN SERUM FERRITIN AND VISCERAL FAT MASS IN AIN SHAMS MEDICAL STUDENTS

2021 ◽  
Vol 72 (3) ◽  
pp. 459-464
Author(s):  
Ehab Emam ◽  
Yasmin El Gendy ◽  
Doaa Ismail
Author(s):  
Hailuan Zeng ◽  
Weihong Sun ◽  
Xinping Ren ◽  
Nan Xia ◽  
Sheng Zheng ◽  
...  
Keyword(s):  
Fat Mass ◽  

1999 ◽  
Vol 82 (11) ◽  
pp. 1490-1496 ◽  
Author(s):  
M. Kockx ◽  
R. Leenen ◽  
J. Seidell ◽  
H. M. G. Princen ◽  
T. Kooistra

SummaryThis study was aimed at evaluating the relationship between visceral fat accumulation and plasma plasminogen activator inhibitor-1 (PAI-1) levels in healthy, obese men and women undergoing weight loss therapy. The subjects, 25 men and 25 premenopausal women, aged between 26 and 49 years, with an initial body mass index between 28 and 38 kg/m2, received a controlled diet for 13 weeks providing a 4.2 MJ/day energy deficit. Magnetic resonance imaging was used to measure visceral and subcutaneous abdominal fat. Our results show that before weight loss visceral fat was significantly correlated with PAI-1 in men (r = 0.45; p <0.05), but not in women (r = -0.15; ns). The association between visceral fat and PAI-1 in men remained significant after adjustment for age and total fat mass, and multiple linear regression analysis showed a significant independent contribution of visceral fat to plasma PAI-1 levels. Both visceral fat areas and PAI-1 levels decreased significantly with weight loss in both men and women. Changes in visceral fat area were related to changes in PAI-1 in women (r = -0.43; p = 0.05) but not in men (r = -0.01; ns); however, this association in women disappeared after adjustment for total fat mass. We conclude that there is a relationship between visceral fat and PAI-1 in obese men but not in obese women, and that PAI-1 levels decrease substantially (52%) by weight loss, but this change is not related to changes in visceral fat mass per se.


2006 ◽  
Vol 154 (1) ◽  
pp. 131-139 ◽  
Author(s):  
Lenora M Camarate S M Leão ◽  
Mônica Peres C Duarte ◽  
Dalva Margareth B Silva ◽  
Paulo Roberto V Bahia ◽  
Cláudia Medina Coeli ◽  
...  

Background: There has been a growing interest in treating postmenopausal women with androgens. However, hyperandrogenemia in females has been associated with increased risk of cardiovascular disease. Objective: We aimed to assess the effects of androgen replacement on cardiovascular risk factors. Design: Thirty-seven postmenopausal women aged 42–62 years that had undergone hysterectomy were prospectively enrolled in a double-blind protocol to receive, for 12 months, percutaneous estradiol (E2) (1 mg/day) combined with either methyltestosterone (MT) (1.25 mg/day) or placebo. Methods: Along with treatment, we evaluated serum E2, testosterone, sex hormone-binding globulin (SHBG), free androgen index, lipids, fibrinogen, and C-reactive protein; glucose tolerance; insulin resistance; blood pressure; body-mass index; and visceral and subcutaneous abdominal fat mass as assessed by computed tomography. Results: A significant reduction in SHBG (P < 0.001) and increase in free testosterone index (P < 0.05; Repeated measures analysis of variance) were seen in the MT group. Total cholesterol, triglycerides, fibrinogen, and systolic and diastolic blood pressure were significantly lowered to a similar extent by both regimens, but high-density lipoprotein cholesterol decreased only in the androgen group. MT-treated women showed a modest rise in body weight and gained visceral fat mass relative to the other group (P < 0.05), but there were no significant detrimental effects on fasting insulin levels and insulin resistance. Conclusion: This study suggests that the combination of low-dose oral MT and percutaneous E2, for 1 year, does not result in expressive increase of cardiovascular risk factors. This regimen can be recommended for symptomatic postmenopausal women, although it seems prudent to perform baseline and follow-up lipid profile and assessment of body composition, especially in those at high risk of cardiovascular disease.


2014 ◽  
Vol 6 (1) ◽  
Author(s):  
Shusuke Yagi ◽  
Muneyuki Kadota ◽  
Ken-ichi Aihara ◽  
Koji Nishikawa ◽  
Tomoya Hara ◽  
...  

2014 ◽  
Vol 14 (1) ◽  
Author(s):  
Yun-Zi Liu ◽  
Ji-Kuai Chen ◽  
Yi Zhang ◽  
Xia Wang ◽  
Shen Qu ◽  
...  
Keyword(s):  
Fat Mass ◽  

2000 ◽  
Vol 8 (2) ◽  
pp. 151-159 ◽  
Author(s):  
Yuling Hong ◽  
Jean-Pierre Després ◽  
Treva Rice ◽  
André Nadeau ◽  
Michael A. Province ◽  
...  

2021 ◽  
Author(s):  
Michael A. Wewege ◽  
Imtiaz Desai ◽  
Cameron Honey ◽  
Brandon Coorie ◽  
Matthew D. Jones ◽  
...  

2005 ◽  
Vol 29 (12) ◽  
pp. 1464-1470 ◽  
Author(s):  
U Salmenniemi ◽  
E Ruotsalainen ◽  
M Vänttinen ◽  
I Vauhkonen ◽  
J Pihlajamäki ◽  
...  

2017 ◽  
Vol 41 (7) ◽  
pp. 1106-1113 ◽  
Author(s):  
T Pallister ◽  
M A Jackson ◽  
T C Martin ◽  
C A Glastonbury ◽  
A Jennings ◽  
...  

2014 ◽  
Vol 19 (6) ◽  
pp. 429-435 ◽  
Author(s):  
Hironobu Sanada ◽  
Hirohide Yokokawa ◽  
Junichi Yatabe ◽  
Scott M. Williams ◽  
Robin A. Felder ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document